Procurement Summary
Country: Germany
Summary: Sale of 7.7 G of Radium-226 for Medical Applications
Deadline: 03 Feb 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 112070407
Document Ref. No.: 783194-2024
Financier: European Commission
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.
Doc Title: Sale of 7.7 g of Radium-226 for medical applications
Contract Type: supplies
Document Type: Prior Information Notice
Reference Number: EC-JRC/KRU/2025/RP/0012-PIN
Contract Type: supplies
Authority Type: eu-ins-bod-ag
Doc Title: Sale of 7.7 g of Radium-226 for medical applications
Dispatch Date: 2024-12-18
Publish Date: 2024-12-20
Submission Date: 2025-02-03
Documents
Tender Notice